Skip to main content
SpringerLink
Log in

Besondere Zirrhoseformen

  • Chapter
Medikamentöse Therapie in der Gastroenterologie

Part of the book series: Kliniktaschenbücher ((KTB))

  • 24 Accesses

Zusammenfassung

Die primär biliäre Zirrhose entwickelt sich aus einer Entzündung an intrahepatischen Gallenwegen. Diese chronische, nicht eitrige, destruierende Cholangitis ist nur langsam progredient. Die Entzündung greift von den Portalfeldern auf das Leberparenchym über und endet schließlich in einer Zirrhose. 90% der Patienten sind Frauen. Die mittlere Lebenserwartung von Patienten mit Symptomen liegt bei ungefähr 10 Jahren [1]. Patienten ohne Symptome haben eine günstige Prognose und entwickeln über Jahre hinweg oft weder Symptome, noch eine Leberzirrhose [2]. Sie bedürfen keiner Therapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Roll J, Boyer J, Klatskin G (1980) Long-term survival of asymptomatic and symtomatic patients with primary biliary cirrhosis. Gastroenterology 79: 1050

    Google Scholar 

  2. James O, Macklon AF, Watson AJ (1981) Primary biliary cirrhosis. Are- vised clinical spectrum. Lancet 1: 1278–1281

    PubMed  CAS  Google Scholar 

  3. Perings E, Junge U (1975) Wirkung und Nebenwirkung von D-Penicillamin. Med Klin 70: 1265–1274

    PubMed  CAS  Google Scholar 

  4. Matloff DS, Alpert E, Resnick RH, Kaplan MM (1982) A prospective trial of D-Penicillamin in primary biliary cirrhosis. N. Engl. J. Med. 306: 319–326

    Article  PubMed  CAS  Google Scholar 

  5. Jain S, Scheurer PJ, Samourian S et al. (1977) A controlled trial of D-Peni- cillamine therapy in primary biliary cirrhosis. Lancet 1: 275–280

    Google Scholar 

  6. Fleming CR, Ludwig J, Dickson ER (1978) Asymptomatic primary biliary cirrhosis. Presentation, histology and results with D-Penicillamine. Mayo Clin Proc 53: 587–593

    PubMed  CAS  Google Scholar 

  7. Epstein O, Jain S, Lee RG et al. (1981) D-Penicillamin treatment improves survival in primary biliary cirrhosis. Lancet 1: 1275–1277

    Article  PubMed  CAS  Google Scholar 

  8. Heathcote J, Ross A, Sherlock S (1976) A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 70: 656–660

    PubMed  CAS  Google Scholar 

  9. Crowe J, Christensen E, Smith M et al. (1980) Azathioprin in primary biliary cirrhosis: A preliminary report of an international trial. Gastroenterology 78: 1005–11010

    PubMed  CAS  Google Scholar 

  10. Taal BG, Schalm SW (1980) Benefits of prednisone therapy in primary biliary cirrhosis. Gastroenterology 79: 1058

    Google Scholar 

  11. Hanid MA, Gevi AJ (1980) Phototherapy for pruritus in primary biliary cirrhosis. Lancet II: 530

    Article  Google Scholar 

  12. Lauterburg H, Taswell HF, Pineda AA et al. (1980) Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads. Lancet II: 53–55

    Article  Google Scholar 

  13. Long RG (1980) Hepatic osteodystrophy: Outlook good but some problems unsolved. Gastroenterology 78: 644–647

    PubMed  CAS  Google Scholar 

  14. Compston JE, Crowe JP, Horton LWL (1979): Treatment of osteomalacia associated with primary biliary cirrhosis with oral 1-alpha-hydroxyvitamine D3. Br Med J 2: 309

    Article  PubMed  CAS  Google Scholar 

  15. Propper RD, Shurin SB, Nathan DG (1976) Reassessment of the use of desferrioxamine B in iron overload. N Engl J Med 294: 1421–1423

    Article  PubMed  CAS  Google Scholar 

  16. Naka GE, Mähring P, Helming M et al (1981) Intravenöse und subkutane Desferaltherapie bei schwerer Eisenüberladung. Therapiewoche 31: 1786–1788

    Google Scholar 

  17. Wapnick AA (1969) The effect of ascorbic acid deficiency on desferriox- amine-induced urinary iron excretion. Br J Haemat 17: 563–568

    Article  CAS  Google Scholar 

  18. Editorial (1981) Wilson’s disease and copper-assosiated protein. Lancet I: 644–646

    Google Scholar 

  19. Lange J (1967) Die Langzeitbehandlung des Morbus Wilson mit D-Penicillamin. Dtsch Med Wochenschr 92: 1657–1662

    Article  PubMed  CAS  Google Scholar 

  20. Walshe JM (1973) Copper chelation in patients with Wilson’s disease: a comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med 42: 441–452

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik, Robert-Koch-Straße 40, 3400, Göttingen, Deutschland

    Priv.-Doz. Dr. med. Ulrich R. Fölsch

  2. Zentrum Innere Medizin, Universität Ulm, Steinhövelstraße 9, 7900, Ulm, Deutschland

    Prof. Dr. med. Ulrich Junge

Authors
  1. Priv.-Doz. Dr. med. Ulrich R. Fölsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Ulrich Junge
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fölsch, U.R., Junge, U. (1982). Besondere Zirrhoseformen. In: Medikamentöse Therapie in der Gastroenterologie. Kliniktaschenbücher. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96689-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-96689-7_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-11389-8

  • Online ISBN: 978-3-642-96689-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation